In this podcast, Motley Fool analyst Jason Moser and host Mary Long discuss the semiconductor supply chain, ASML's earnings, ...
The genetic-testing company 23andMe is facing financial difficulties, raising concerns about the privacy and security of its ...
The entire board of DNA testing company 23andMe resigned after a conflict with CEO Anne Wojcicki over her plan to take the ...
Overview of the Recent Transaction On September 30, 2024, SC US (TTGP), LTD., a prominent investment firm, initiated a new ...
A giant biotechnology company might be about to go bust. What will happen to the millions of people’s DNA it holds?
Since it was founded nearly two decades ago, 23andMe has grown into one of the largest biotechnology companies in the world.
A spokesperson for 23andMe would not comment to NPR on what will happen to genetic data, except to express the company’s ...
The blue-chip board and the startup star had been on a collision course for months. Here’s what really happened.
Anne Wojcicki, CEO of 23andMe, the struggling DNA testing company, doesn’t think this is the right time to examine her ...
Gray’s optimism on IPO markets provided a positive gloss to its muted asset sales in third-quarter results released on Thursday. The biggest story at Blackstone is its continued growth in almost any ...